Solarvest BioEnergy Grants Options
January 28 2011 - 6:47PM
Marketwired
SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the
"Company"), is pleased to announce that, in accordance with the
Company's Stock Option Plan, it has granted to certain directors,
officers, employees and consultants, incentive stock options to
purchase up to an aggregate of 600,000 common shares exercisable at
a price of $0.25 per share for a period of five years from the
grant date. This includes a grant of 70,000 options to an officer
and director who is also a Control Person of the Company and is
exempt from shareholder approval accordance with section 5.7(1)(a)
of MI 61-101.
About Solarvest: Solarvest is committed to the development of
sustainable and renewable energy sources to meet growing energy
demands and environmental challenges. Solarvest's intellectual
property is a biologically-based hydrogen producing technology,
which provides a method for controlling key genes in algae
resulting in the continuous production of hydrogen gas. Solarvest's
bio-energy production system utilizes light and carbon dioxide to
produce hydrogen leaving a clean positive environmental
footprint.
The statements made in this news release may contain
forward-looking statements that may involve a number of risks and
uncertainties. Actual events or results could differ materially
from the Company's expectations and projections.
The TSX Venture Exchange has neither approved nor disapproved
the contents of this news release.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Contacts: Solarvest BioEnergy Inc. Gerri Greenham Chief
Executive Officer 416 420 0947 ggreenham@solarvest.ca
Solarvest BioEnergy (TSXV:SVS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Solarvest BioEnergy (TSXV:SVS)
Historical Stock Chart
From Jul 2023 to Jul 2024